Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INCITE LS: A Clinical Evaluation of the Aliya™ System in Late Stage Cancer

NCT04773275 is registered in ClinicalTrials.gov with Galvanize Therapeutics, Inc. as lead sponsor.

NCT NCT04773275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04773275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INCITE LS: A Clinical Evaluation of the Aliya™ System in Late Stage Cancer
Lead sponsor
Galvanize Therapeutics, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
May 9, 2022
Completion date
April 21, 2023
Enrollment
4 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of lung, kidney or liver